GEN Exclusives

More »


More »
Apr 15, 2010 (Vol. 30, No. 8)

Request for Proposals for Better Multiple Sclerosis Therapies

  • EMD Serono and Fast Forward put out a request for proposals (RFPs) from academic groups and emerging biotech and pharmaceutical firms involved in multiple sclerosis R&D programs. RFPs are being accepted now through the EMD Serono Collaborative Fund for projects in the following target areas: therapeutic strategies to modulate the innate immune system in the CNS, and therapeutic strategies to promote axonal protection, restoration, and function through CNS-targeted mechanisms including modulation of CNS ion channels. Applications will be considered until June 1, 2010.

    For more information and to apply for the RFP please visit

    For investigators and companies interested in learning more about this RFP and program, there will be a live teleconference April 23. Email: [email protected] for details.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »